Status:
UNKNOWN
Austrian COVID-19 Registry
Lead Sponsor:
Arbeitsgemeinschaft medikamentoese Tumortherapie
Conditions:
Infectious Disease
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
The AGMT\_COVID-19 Registry is designed as multicenter observational cohort of patients, that are tested positive for SARS-CoV-2. Data will be collected from all sites in Austria willing to participat...
Detailed Description
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The disease was first identified at the end of 2019 in Wuhan, the c...
Eligibility Criteria
Inclusion
- Age \>=18 years
- Positive test for SARS-CoV-2
Exclusion
- Due to the non-interventional design of the registry there are no specific exclusion criteria.
Key Trial Info
Start Date :
April 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2021
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04351529
Start Date
April 1 2020
End Date
December 1 2021
Last Update
November 30 2020
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
LKH Feldkirch: Innere Medizin II/ Interne E (Hämatologie und Onkologie)
Feldkirch, Austria, 6807
2
Kepler Universitätsklinikum Linz, Med. Campus III., Klinik für Lungenheilkunde / Pneumologie
Linz, Austria, 4021
3
IIIrd Medical Department, Private Medical University Hospital Salzburg
Salzburg, Austria, 5020
4
KH Zams: Innere Medizin Internistische Onkologie und Hämatologie
Zams, Austria, 6511